Home - Products - Others - Other Targets - 5-Hydroxymethyldeoxyuridine

5-Hydroxymethyldeoxyuridine

CAS No. 5116-24-5

5-Hydroxymethyldeoxyuridine ( —— )

Catalog No. M24477 CAS No. 5116-24-5

5-Hydroxymethyldeoxyuridine is an analog of nucleoside that has anticancer and antiviral activities.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
10MG	37	In Stock
25MG	59	In Stock
50MG	104	In Stock
100MG	178	In Stock
200MG	268	In Stock
500MG	Get Quote	In Stock
1G	Get Quote	In Stock

Group Booking Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

5-Hydroxymethyldeoxyuridine
Note

Research use only, not for human use.
Brief Description

5-Hydroxymethyldeoxyuridine is an analog of nucleoside that has anticancer and antiviral activities.
Description

5-Hydroxymethyldeoxyuridine is an analog of nucleoside that has anticancer and antiviral activities. It suppresses the replication of murine S180 lung carcinoma cells and Ehrlich ascites mammary carcinoma cells (ED50s = 8.5 and 4 μM, respectively) and multiple human leukemia cell lines (IC50s = 1.7-5.8 μM).
Synonyms

——
Pathway

Others
Target

Other Targets
Recptor

others
Research Area

——
Indication

——

Chemical Information

CAS Number

5116-24-5
Formula Weight

258.2
Molecular Formula

C10H14N2O6
Purity

>98% (HPLC)
Solubility

DMSO:Soluble
SMILES

OC[C@H]([C@H](C1)O)O[C@H]1N(C=C(CO)C(N1)=O)C1=O
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

6-Methoxyflavanone

6-Methoxyflavanone (6-MeOF) is A positive allosteric modulator of the GABA response of human recombinant GABA A receptor, with antianxiety and anti-inflammatory activity, and can be used to reduce cisplatin induced neuropathic pain.
Albendazole Oxide

Albendazole is a tubulin polymerization or assembly inhibitor, used for the treatment of a variety of parasitic worm infestations.
LY-3475070

LY-3475070 is a potent and selective CD73 inhibitor with an IC50 of 28 nM, and its use alone or in combination with pembrolizumab is currently being tested in patients with advanced cancer.

Sign In Join Free